🔗 Visit the ClinicalTrials.gov page for NCT00883116
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial watch: Chemotherapy with immunogenic cell death inducers. | Oncoimmunology | 2012 | 1.33 |
| 2 | Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer. | Gynecol Oncol | 2015 | 0.79 |
| 3 | Clinicopathologic study in uterine cancer. | Facts Views Vis Obgyn | 2011 | 0.75 |